Monitoring of Early Warning Indicators for HIV Drug Resistance in Antiretroviral Therapy Clinics in Zimbabwe

Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support national program and clinic-level adjustments, if neces...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2012-05, Vol.54 (suppl_4), p.S313-S316
Main Authors: Dzangare, J., Gonese, E., Mugurungi, O., Shamu, T., Apollo, T., Bennett, D. E., Kelley, K. F., Jordan, M. R., Chakanyuka, C., Cham, F., Banda, R. M.
Format: Article
Language:English
Subjects:
Abstract art
Adult
African art
Anti-Retroviral Agents - pharmacology
Anti-Retroviral Agents - supply & distribution
Anti-Retroviral Agents - therapeutic use
Antiretroviral drugs
Antiretrovirals
Antivirals
Drug resistance
Drug Resistance, Viral
HIV
HIV Infections - drug therapy
HIV Infections - epidemiology
Human immunodeficiency virus
Humans
Lost to Follow-Up
Medical practice
National Health Programs
Patient Compliance - statistics & numerical data
Pharmacies
Population Surveillance
Supplement
Warnings
World Health Organization
Zimbabwe - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support national program and clinic-level adjustments, if necessary. World Health Organization—recommended HIVDR EWIs were monitored in Zimbabwe using routinely available data at selected ART clinics between 2007 and 2009. As Zimbabwe's national ART coverage increases, improved ART information systems are required to strengthen routine national ART monitoring and evaluation and facilitate scale-up of HIVDR EWI monitoring. Attention should be paid to minimizing loss to follow-up, supporting adherence, and ensuring clinic-level drug supply continuity.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/cir1014